INTERAKSI HETEROTROPIK DAN BIOLOGI
ANGIOGENESIS
Stromal components in Breast, colon, stomach and pankreas, : 90% of non neoplastic cells in tumor mass
High grade invasive ductal carcinoma of the breast
Neoplastic cells are in continuous
communication with their non-neoplastic neighbors
Hodgkin’s disease: Lymphoma –
tumor development began
– Various signals from the cells involve multiple distinct cell types differentiation program heterotypic signaling (signal from various type of cells) to encourage or limit cell proliferation
CD34-antigen-positive fibroblast
CD117 antigen-
positive mast cells -smooth muscle actin- positive myofibroblasts
Stroma of squamous cell carcinomas of the oral cavity, pharynx, larynx
• Heterotyping signaling channels depend on :
– Mitogenic growth factors: HGF, TGF-, PDGF – Growth-inhibitory
signals: TGF-β – Trophic factors:
Insulin-like growth factor-1 & -2
• Heterotypic interaction play an
important role in driving many types of tumor promotion in during initial formation of
tumors.
Heterotypic interaction
•
during initial formation of tumors:
– play an important role in driving many types of tumor promotion
•
Tumor development:
– Carcinoma cells release PDGF stromal cells have receptor for PDGF because of this inducer, stromal cells produce IGF-1 benefits for the growth & survival of cancer cells
– Stromal & epithelial cells collaborate in construction of ECM
– Endothelial cells –blood vessels & lymphatic ducts : vital component of normal & cancer tissue:
• Endothelial cells secrete growth factors that stimulate proliferation of nearby nonendothelial cells
Venule/arteriol Green:endothelial
Capilary vessels Green:endothelial
• Heterotypic interaction maintain normal function continue to operate within
carcinomas, being required for the neoplastic cells to thrive and multiply within these
tumors.
Tumor ~ wounded tissue
Wound tissue PDFG & TGF-
Permeability blood vessels Attract fibroblast + proliferation MMP + FGF
attract inflamatory cells
mitogenic factors stimulate endothelial cells
angiogenesis /neoangiogenesis
• In tumor :
– Release PDGF attractant & mitogen for stromal cells
stromalization
– Tumor-associated myofibroblasts from normal stromal fibroblast desmoplastic stroma hardness of tumor mass deposition of extensive ECM collagen I, III, fibronectin, proteoglycans, gycosaminoglycans, uPA (urokinase plasminogen activator), MMP
– Carcinoma-associated fibroblasts (CAFs): mixed of fibroblasts and myofibroblasts
Stromal cells : active contributors to tumorigenesis
• Inaktivasi reseptor TGF-β-II pada sel fibroblas aktivasi hiperproliferasi sel stroma karsinoma pada sel epitel prostat perlu sekali peranan fibrolas
Stromal cells : active contributors to tumorigenesis
• MEC + mammary stromal fibroblast (normal) tumor
txHMEC =
tumorigenic human mammary
epithelial cells
Figure 13.21 The Biology of Cancer (© Garland Science 2007)
• Myofibroblast ekspresi VEGF bentuk
neovasculatura
Macrophages
• Macrophage :
– Monocyte chemotactic protein-1
• macrophage chemoattractant protein
• expressed by neuroectodermal and epithelial cancer cell types.
– VEGF, CSF-1, PDGF recruit macrophage – CSF-1 monocyte macrophage
differentiation
• Macrophages in tumor play important roles in stimulating angiogenesis.
• Cancer cells/chemokine attract more macrophages secrete important angiogenic factors : VEGF & IL-8
• Hypoxic areas within tumors attract macrophages VEGF secretion
• Macrophages + myofibroblast : secrete MMP
• MMP-9
– Produced by Tumor –associated macrophages – involved in tumor progression
• By enhancing angiogenesis
• By disrupting existing tissue structure
• By liberating critical mitogens that have been immobilized through tethering to proteoglycans of the ECM.
– MMP9 cleave IGFBP sequester IGF in the extracellular space.
• Two types of Macrophage :
– 1st : Active collaborators in tumor progression, some cancer cells acquire the ability to inactivate or blunt the tumoricidal actions of the second type of macrophage
•
Tumor cells grew preferentially around blood vessels.
•
Tumor cells which were located
– more than 0.2 mm away from blood cells nongrowing – Farther away dying
• 0,2 mm distance that oxygen can effectively
diffuse through living tissues
•
Tissue suffered from hypoxia in danger of becoming necrotic
•
Vasculature growth & survival of all types of tissue, normal & neoplastic
nekrotik nekrotik
hypoxia oxygenated
Mouse cornea:
wounding induces angiogenesis, chemotactic response to angiogenic factors
Angiogenesis:
Sprouting of cells from mature endothelial cells of the vessel wall
secretion of proteases, resolution of basal lamina, migration towards chemotactic gradient, proliferation,
VEGF is factor largely specific for endothelial cells,
bFGF can also induce,
tip cell stem
• Layout of vasculature
– Is not regulated genetically
– Depend on the localized heterotypic interactions between the cells of the vasculature (incl.
endothelial, pericytes, smooth muscle cells) and nonvascular cells (incl. neoplastic cells and other types of the supporting stroma)
– Two ways of vasculature assembling:
• Myofibroblasts in tumor associated stroma release chemotactic signals : SDF-1/CXCL12 recruit circulating endothelial precursors to the stroma
• Recruitment is also aided by VEGF
• Lymphatic vessels formation is needed for regulators of fluid balance in the tumor stroma.
• Other factor for angiogenesis:
– TGFβ – bFGF – Interleukin-8 – Angiopoietin – Angiogenin – PDGF
• Capillaries in tumor :
– 3 x greater in diameter than normal
– Layout of blood vessels around and within tumor masses quite chaotic – Plasma membranes of adjacent endothelial cells do not contact one another
leave gaps allow direct access of blood plasma to the cells surrounding the capillary responsible for the deposition of fibrin in tumor parenchyma – Walls of capillaries : 10x more permeable than normal due to the
deregulated production of VEGF within tumors
gap
Chaotic organization of tumor- associated vasculature
• Leakiness of tumor associated capillaries
Accumulation of substantial amounts of fluid in the parenchymal spaces
within a tumor
– Normally these fluid are drained by lymphatic vessels
• Solid tumor cancer cells exerts
pressure on lymphatic vessels
collapse of lymphatic vessels
• in rip-tag model of islet cell tumor progression, Angiogenic switch involves heterotypic interactions among 3 distinct
cell types:
– The release of
still-unidentified signals from the pre-malignant islet cells that recruit mast cells & quite possible macrophages
– The release of MMP-9 by inflammatory cells to activate latent VEGF – Proliferative response of
endothelial cells to activated VEGF
Figure 13.37 The Biology of Cancer (© Garland Science 2007)
The Rip-Tag model of islet tumor cell progression
Transgene: SV40 large and small T transcription driven by insulin promoter Transcription in b-cells of islets of Langerhans
Figure 13.38b The Biology of Cancer (© Garland Science 2007)
The angiogenic switch and recruitment of inflammatory cells
suppressed by physiologic
inhibitors
Stimulation of resting endothelial cells with angiogenic agents creates activated, growing endothelial cells, which soon express the Fas death receptor on their surface. Treatment of mature and recently formed endothelial cells with Tsp causes both groups of cells to secrete FasL. bind to FasR apoptosis
Figure 1: Interaction between gastric cancer cells and stromal cells influences angiogenesis and lymphangiogenesis through various angiogenic factors and
cytokines. Yasuhiko Kitadai, J.Oncol. Volume 2010
Figure 13.47a The Biology of Cancer (© Garland Science 2007)